Chen, Zhong http://orcid.org/0000-0002-9644-1737
Hankey, William http://orcid.org/0000-0001-5935-2391
Zhao, Yue http://orcid.org/0000-0002-0110-0359
Groth, Jeff
Huang, Furong
Wang, Hongyan
Campos, Alexandre Rosa
Huang, Jiaoti
Roeder, Robert G.
Wang, Qianben http://orcid.org/0000-0003-2636-7145
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R50 CA251843, R01 CA200853, GM 120221)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 19 February 2020
Accepted: 17 October 2021
First Online: 3 November 2021
Competing interests
: J.H. is a consultant for or owns shares in the following companies: Kingmed, MoreHealth, OptraScan, Genetron, Omnitura, Vetonco, York Biotechnology, Genecode, VIVA Biotech, and Sisu Pharma, and received grants from Zenith Epigenetics, BioXcel Therapeutics, Inc., and Fortis Therapeutics. The other authors declare no competing interests.